Physician Communication That Combined Results Of Unrelated Studies Gets Rebuke From US FDA

 
• By Brenda Sandburg
  
Two studies
US FDA objects to Roszet drug promotion combining the results of two studies • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance